Nehal Mohamed

Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

Meletios Α. Dimopoulos, Philippe Moreau, Antonio Palumbo et al. · The Lancet Oncology · 2015 · 834 citations · Full text

Hematological Malignancy, Oncology, Dexamethasone Versus Bortezomib +8

A High-Affinity Monoclonal Antibody to Anthrax Protective Antigen Passively Protects Rabbits before and after Aerosolized <i>Bacillus anthracis</i> Spore Challenge

Nehal Mohamed, Michelle Clagett, Juan Li et al. · Infection and Immunity · 2005 · 123 citations · Full text

Veterinary Vaccine, Immunology, Biological Therapy +16

Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study

Philippe Moreau, D. Joshua, W-J Chng et al. · Leukemia · 2016 · 76 citations · Full text

Hematological Malignancy, Relapsed Multiple Myeloma, Medicine +13

Novel experimental study of receptor-mediated bacterial adhesion under the influence of fluid shear

Nehal Mohamed, Thomas R. Rainier, Julia Ross · Biotechnology and Bioengineering · 2000 · 69 citations

Tissue Engineering, Engineering, Cell Adhesion +22

Enhancement of Anthrax Lethal Toxin Cytotoxicity: a Subset of Monoclonal Antibodies against Protective Antigen Increases Lethal Toxin-Mediated Killing of Murine Macrophages

Nehal Mohamed, Juan Li, Cláudia S. Ferreira et al. · Infection and Immunity · 2004 · 62 citations · Full text

Inflammation, Immunotoxicology, Microbial Pathogens +15